Berry Street, a US-based nutrition startup, has merged with Healthify, India's leading metabolic health platform, creating a combined entity positioned to capitalize on the global GLP-1 boom. Noah Kotlove, Berry Street's founder, and Tushar Vashisht, Healthify's founder, will lead the merged company as co-CEOs.
The merger pairs two regional leaders in personalized nutrition and metabolic health at a time when GLP-1 receptor agonists like Ozempic and Wegovy have triggered massive consumer interest in weight loss, diabetes management, and preventive health. Berry Street built its US presence by offering personalized nutrition guidance and meal planning, while Healthify established dominance in India's digital health sector with a focus on metabolic disorders, chronic disease management, and telemedicine-enabled nutrition coaching.
The combination creates a cross-border player with footprints in two massive markets. India's health-conscious middle class represents hundreds of millions of potential customers, while the US market has exploded with demand for medical weight loss support as GLP-1 adoption accelerates. The merger allows both founders to leverage their respective expertise without either ceding control, hence the co-CEO structure.
Kotlove and Vashisht bring complementary strengths. Kotlove built Berry Street as a direct-to-consumer nutrition tech platform, while Vashisht scaled Healthify to serve both consumers and institutional clients, including corporate wellness programs and hospital systems. The integration positions the merged entity to serve multiple customer segments across geographies.
The timing reflects a fundamental shift in how nutrition startups compete. Previously, many positioned themselves as lifestyle or wellness plays. Today, the GLP-1 wave has reframed nutrition and metabolic health as medical categories. Companies that can integrate meal planning, behavioral coaching, lab work, and pharmaceutical management into a coherent offering have clear revenue advantages. Insurance reimbursement for remote patient monitoring and lifestyle interventions has also improved, changing unit economics for health-tech providers.
The merged company will inherit Healthify's established clinical network in India and Berry Street's consumer brand recognition and product sophistication in the US market. Neither company has disclosed the financial terms of the merger, but both were well-capitalized prior to the combination, suggesting this was a strategic consolidation rather than a rescue scenario.
Competitors in this space include Noom, which has also attempted to position itself as a GLP-1 companion platform, and regional players like Cure.fit in India and companies like Carbon Health in the US that blend nutrition with direct medical services. The Berry Street/Healthify combination competes on scale and geography while maintaining founder involvement at the CEO level, a structure that often appeals to early-stage investors as a signal of continued founder commitment.
The merger also reflects a broader consolidation trend in health-tech, where fragmented regional players recognize the need for scale and cross-border capabilities to compete against well-funded US incumbents and expanding Indian health-tech platforms.